Obstructive sleep apnea, hypertension, and cardiovascular risk: epidemiology, pathophysiology, and management
LA Salman, R Shulman, JB Cohen - Current Cardiology Reports, 2020 - Springer
Abstract Purpose of Review Given the rising prevalence of obstructive sleep apnea (OSA),
we aimed to review the epidemiologic and pathophysiologic relationship of OSA …
we aimed to review the epidemiologic and pathophysiologic relationship of OSA …
Sleep Disordered Breathing and Cardiovascular Disease: JACC State-of-the-Art Review
Sleep disordered breathing causes repetitive episodes of nocturnal hypoxemia, sympathetic
nervous activation, and cortical arousal, often associated with excessive daytime sleepiness …
nervous activation, and cortical arousal, often associated with excessive daytime sleepiness …
International consensus statement on obstructive sleep apnea
JL Chang, AN Goldberg, JA Alt… - International forum of …, 2023 - Wiley Online Library
Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …
allows for consolidation and determination of the key factors important for clinical …
Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: systematic review and meta …
G Labarca, J Dreyse, L Drake, J Jorquera… - Sleep medicine reviews, 2020 - Elsevier
Obstructive sleep apnea (OSA) commonly occurs in patients with increased cardiovascular
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …
(CV) risk, and continuous positive airway pressure (CPAP) is the preferred therapy for these …
[HTML][HTML] Cardiovascular disease outcomes associated with obstructive sleep apnea in diabetics: a systematic review and meta-analysis
Background: There is significant pathogenic and epidemiological overlap between diabetes
and obstructive sleep apnea (OSA). This systematic review aimed to ascertain the …
and obstructive sleep apnea (OSA). This systematic review aimed to ascertain the …
Continuous positive airway pressure and adverse cardiovascular events in obstructive sleep apnea: are participants of randomized trials representative of sleep clinic …
A Reynor, N McArdle, B Shenoy, SS Dhaliwal, SC Rea… - Sleep, 2022 - academic.oup.com
Abstract Study Objectives Randomized controlled trials (RCTs) have shown no reduction in
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …
adverse cardiovascular (CV) events in patients randomized to continuous positive airway …
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents
E Belaidi, C Khouri, O Harki, S Baillieul… - European …, 2022 - Eur Respiratory Soc
Aim Intermittent hypoxia (IH) is considered to be a major contributor to obstructive sleep
apnoea-related cardiovascular consequences. The present meta-analysis aimed to assess …
apnoea-related cardiovascular consequences. The present meta-analysis aimed to assess …
[HTML][HTML] Investigating the relationship between obstructive sleep apnoea, inflammation and cardio-metabolic diseases
A Alterki, M Abu-Farha, E Al Shawaf, F Al-Mulla… - International journal of …, 2023 - mdpi.com
Obstructive sleep apnoea (OSA) is a prevalent underdiagnosed disorder whose incidence
increases with age and weight. Uniquely characterised by frequent breathing interruptions …
increases with age and weight. Uniquely characterised by frequent breathing interruptions …
Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta …
Introduction Obstructive sleep apnoea (OSA) is highly prevalent in patients with
cardiovascular risk factors and is associated with increased morbidity and mortality. This …
cardiovascular risk factors and is associated with increased morbidity and mortality. This …
Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway
P Guan, ZM Sun, N Wang, J Zhou, LF Luo, YS Zhao… - Life sciences, 2019 - Elsevier
Aims Resveratrol is a polyphenolic compound that has received much attention for its use in
ameliorating various systemic pathological conditions. The present study was performed to …
ameliorating various systemic pathological conditions. The present study was performed to …